Claims for Patent: 11,583,542
✉ Email this page to a colleague
Summary for Patent: 11,583,542
| Title: | Compositions of bile acids and phenylbutyrate compounds |
| Abstract: | The present disclosure relates to compositions including a phenylbutyrate compound and a bile acid, and methods of processing such compositions. |
| Inventor(s): | Joshua Cohen, Justin Klee, David Wai Fung Ma |
| Assignee: | Amylyx Pharmaceuticals Inc |
| Application Number: | US16/940,102 |
| Patent Claims: |
1. A composition comprising: (a) about 27% to about 32% w/w of sodium phenylbutyrate; (b) about 8% to about 12% w/w of taurursodiol (TURSO); (c) about 14% to about 17% w/w of dextrates; (d) about 3.5% to about 4.5% w/w of sorbitol; (e) about 25% to about 32% w/w of maltodextrin; and (f) about 0.05% to about 1.5% w/w of porous silica, wherein the sodium phenylbutyrate and the TURSO have a ratio by weight of about 3:1, and wherein the composition has a measurable Carr's index of about 24 or less. 2. The composition of claim 1, comprising about 9% to about 10% w/w of TURSO. 3. The composition of claim 1, wherein the maltodextrin is pea maltodextrin. 4. The composition of claim 1, further comprising about 0.5% to about 5% w/w of sucralose. 5. The composition of claim 4, comprising about 1% to about 3% w/w of sucralose. 6. The composition of claim 1, further comprising about 2% to about 15% w/w of one or more flavorants. 7. The composition of claim 1, wherein the porous silica has an average pore volume of about 0.1 cc/gm to about 2.0 cc/gm. 8. The composition of claim 1, wherein the porous silica has a bulk density of about 100 g/L to about 600 g/L. 9. The composition of claim 1, further comprising about 0.5% to about 5% w/w of a buffering agent. 10. The composition of claim 9, wherein the buffering agent is sodium phosphate dibasic. 11. The composition of claim 10, comprising about 1% to about 4% w/w of sodium phosphate dibasic. 12. The composition of claim 1, further comprising about 0.05% to about 1% w/w of one or more lubricants. 13. The composition of claim 12, wherein the one or more lubricants are selected from the group consisting of: sodium stearyl fumarate, magnesium stearate, stearic acid, polyethylene glycol, glyceryl behenate, and hydrogenated oil. 14. The composition of claim 13, wherein the one or more lubricants is sodium stearyl fumarate. 15. The composition of claim 14, comprising about 0.2% to about 0.8% w/w of sodium stearyl fumarate. 16. The composition of claim 1, wherein the composition has a measurable Carr's index of about 20 or less. 17. The composition of claim 1, wherein the composition has a Carr's index of about 21. 18. The composition of claim 1, wherein the composition has a Carr's index of about 22. 19. The composition of claim 1, wherein the composition has a Carr's index of about 23. 20. The composition of claim 1, wherein the composition has a Carr's index of about 24. 21. A composition comprising: about 29.2% w/w of sodium phenylbutyrate; about 9.7% w/w of taurursodiol (TURSO); about 15.6% w/w of dextrates; about 3.9% w/w of sorbitol; about 1.9% w/w of sucralose; about 28.3% w/w of maltodextrin; about 7.3% w/w of flavorants; about 0.9% w/w of porous silica; about 2.7% w/w of sodium phosphate dibasic; and about 0.5% w/w of sodium stearyl fumarate, wherein the composition has a measurable Carr's index of about 24 or less. |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
